Detection of 41-kDa bacterial flagellin protein by the lymphocyte transformation test-memory lymphocyte immunostimulation assay
- PMID: 36187894
- PMCID: PMC9520187
Detection of 41-kDa bacterial flagellin protein by the lymphocyte transformation test-memory lymphocyte immunostimulation assay
Abstract
Background/objectives: Diagnosis of human infection by various species of the bacterial genus Borrelia is mainly reliant on serological testing, polymerase chain reaction (PCR) or culture but such serological tests have been reported to have heterogeneous sensitivities, while Borrelia PCR and culture have been reported as being of modest diagnostic value. It has been suggested that the adjunctive use of the lymphocyte transformation test-memory lymphocyte immunostimulation assay (LTT-MELISA) may be helpful in this regard; however, the clinical usefulness of this assay has been questioned. The Borrelia immunodominant 41-kDa flagellin protein almost always gives rise to a marked human antibody response following infection. It was therefore decided to determine whether the LTT-MELISA detects the human antibody response to this antigen.
Methods: Blood samples from consecutive patients with possible borreliosis attending a clinic were independently tested by both Western blots and LTT-MELISA.
Results: After omitting cases with indeterminate Western blot results and equivocal LTT-MELISA results, multiple linear regression modelling demonstrated that the 41-kDa flagellin immunoglobulin (Ig) M level was predictable from two LTT-MELISA variables (F 2,51 = 5.981, P = 0.005). Similarly, the corresponding 41-kDa IgG model also contained two LTT-MELISA variables (F 2,57 = 3.700, P = 0.031).
Conclusion: It is concluded that the LTT-MELISA appears to be able to detect the response to this antigen.
Keywords: Flagellin; MELISA; lymphocyte transformation test.
AJCEI Copyright © 2022.
Conflict of interest statement
None.
Similar articles
-
Diagnostic use of the lymphocyte transformation test-memory lymphocyte immunostimulation assay in confirming active Lyme borreliosis in clinically and serologically ambiguous cases.Int J Clin Exp Med. 2014 Dec 15;7(12):5890-2. eCollection 2014. Int J Clin Exp Med. 2014. PMID: 25664127 Free PMC article.
-
A novel lymphocyte transformation test (LTT-MELISA) for Lyme borreliosis.Diagn Microbiol Infect Dis. 2007 Jan;57(1):27-34. doi: 10.1016/j.diagmicrobio.2006.06.008. Epub 2006 Jul 28. Diagn Microbiol Infect Dis. 2007. PMID: 16876371
-
LTT-MELISA is clinically relevant for detecting and monitoring metal sensitivity.Neuro Endocrinol Lett. 2006 Dec;27 Suppl 1:17-24. Neuro Endocrinol Lett. 2006. PMID: 17261998
-
Are Allergy-Induced Implant Failures Actually Hypersensitivity Reactions to Titanium? A Literature Review.Dent J (Basel). 2023 Nov 9;11(11):263. doi: 10.3390/dj11110263. Dent J (Basel). 2023. PMID: 37999027 Free PMC article. Review.
-
Western blot as a tool in the diagnosis of Lyme borreliosis.Electrophoresis. 1993 Sep;14(9):937-44. doi: 10.1002/elps.11501401149. Electrophoresis. 1993. PMID: 8223404 Review.
References
-
- Fumarola D. Endotoxicity of newly recognized gram negative organism: a collective review. Boll Ist Sieroter Milan. 1985;64:255–261. - PubMed
-
- Howe TR, Mayer LW, Barbour AG. A single recombinant plasmid expressing two major outer surface proteins of the Lyme disease spirochete. Science. 1985;227:645–646. - PubMed
LinkOut - more resources
Full Text Sources